Ever Wondered How Alcohol Affects the Nervous System?

Not only in the UK, but all around the world, alcohol is enjoyed by many - drinking is indeed a popular pastime. However, when individuals over-indulge, it can lead to serious health problems including addition even though this is not very common. Nevertheless, in the UK, the NHS estimates that '9% of men and 4% of women show signs of alcohol dependence' (Source: DrinkAware). Over the decades, interest has increased around the effects of alcohol, not only on the physical but also on the mental state. In medicine, researchers will endeavour to find a physiological mechanism to a unexplained mental or behavioural phenomenon. A perfect example of this is the effect of various drugs, illegal and legal, on human behaviour. Quite a few of these substances cause imbalances in the amount of neurotransmitter released from pre-synaptic vesicles into the synaptic cleft in particular areas of the brain. In turn, the frequency of electrical impulses transmitted can fluctuate which can ultimately influence behaviour. To understand this better, it is beneficial to look back in history when the basic physiology and chemistry were uncovered.

Above: Scanning electron micrograph of neurotransmitter-containing vesicles (orange and blue) being released from a pre-synaptic neuron (Source: AnatomyBox)

Pre-1930s, there were noticeable disagreements between academics on how exactly neurons communicate their signals to one another. Was it electrical or was it chemical? It wasn't until 1936, when Sir Henry Dale and Otto Loewi received the Nobel Prize in Physiology or Medicine, that it became clear that these signals were indeed due to chemical transmission. This is possible through the action of neurotransmitters - chemicals which are released into the space between neuron, the synaptic cleft. Some scientists prior to this award did suggest that chemicals were involved, through observing the similarities in nerve stimulation in plants and animals (Source: NobelPrize.org) Loewi managed to illustrate the importance of these chemicals in an elegant way using experiments on frogs. His papers were published in 1921 - these showed that nerve impulses affected the heart using chemical transmission. Firstly, Loewi stimulated the vagus nerve fibres of an isolated frog's heart that had been connected on the other side to a ringer solution. Soon after this, he observed that the strength and frequency of the heartbeat decreased. The fluid remaining was used to surround another frog heart - the vagus nerves were not electrically stimulated. This time, the heart changed it's activity as if it had been electrically stimulated (Source: AnimalResearch.info) It seemed that the fluid has caused this change. Dale's discovery of the action of acteylcholine was inline with Loewi's results and so after subsequent years of research, Dale and Loewi were awarded the Nobel Prize in Physiology or Medicine. 

Chemical transmission is an important concept to understand when we consider how an impulse is able to transmit from neuron to neuron in the brain. It can be understood as a cascade of events beginning with the arrival of an action potential at the axon terminal of the pre-synaptic neuron. The depolarisation stimulates calcium ion channels to open, causing an influx of Ca²⁺ into the axon. This in turn stimulates vesicles filled with neurotransmitter to migrate to the end of the axon. The vesicles are then able to fuse with the lipid bi-layer membrane to release the neurotransmitter (e.g. acetylcholine) into the synaptic cleft. When these neurotransmitters bind to ligand-gated sodium channels on the post-synaptic neuron, this triggers another action potential to fire. To prevent constant firing of action potentials, a neurotransmitter such as acetylcholine is broken down by an enzyme (in this case, acetylcholinesterase), and the inactive products are reabsorbed by the pre-synaptic neuron through re-uptake transporters. These events will become important when we look at the effect of alcohol on the nervous system.

Above: Schematic diagram showing the transmission of an action potential  (Source: Biological Sciences Review Volume 26, Number 2).

Now, alcohol is one of the few substances than can cross what is referred to in anatomy as the blood-brain barrier (BBB). This is largely a fatty barrier than surrounds the blood vessels in the brain. In medical research, this barrier has been notoriously difficult to overcome when delivering drugs or attempting to treat an array of brain-related diseases, for example Alzheimer's. Until very recently, this has caused problems, however scientists have now found a way of delivering cancer-fighting drugs to targets by breaching the blood-brain barrier. A research team in Canada used 'tiny gas-filled bubbles, injected into the bloodstream of a patient, to punch temporary holes in the blood-brain barrier'. Following this, ultrasound was used to make the bubbles 'vibrate and push their way through, along with chemotherapy drugs' (Source: BBC) This has been a significant breakthrough - I encourage you to read more on the subject here.

The reason that alcohol is able to cross this barrier is that it is lipid soluble. Once alcohol crosses the barrier, it is able to affect the action of neurotransmitters. Before looking at how alcohol comes into play, it is useful to consider the different types of neurotransmitter that exist in the nervous system, and their different modes of action.

Neurotransmitters can either be excitatory (increases the likelihood of an action potential being fired on the post-synaptic neuron) or inhibitory (decreases the likelihood). Examples of excitatory neurotransmitters are glutamate, dopamine and acetylcholine. Glutamate is the most common kind of neurotransmitter in the brain and is thought to be involved in memory and learning. The well-known neurotransmitter dopamine is involved in the mechanisms of motivation and reward. It follows that many addictive drugs utilise the 'feel good' sensation that dopamine causes. And finally, acetylcholine is most commonly used in the contraction of involuntary muscle - it can be released at the site of a neuromuscular junction. A good example of an inhibitory neurotransmitter is gamma-amino butyric acid (GABA) - it's action is known to reduce stress. In fact, about a third of all brain synapses use GABA, and anti-anxiety drugs such as Valium enhance it's action. Another example of an inhibitory neurotransmitter is the amino acid glycine, however this is used mainly in the spinal cord, and is involved in about half of all synapses there, the rest using GABA. (Source: Principles of Anatomy and Physiology 13th edition - G.J. Tortora and B. Derrickson)

Above: The structure of common neurotransmitters (Source: CompoundChem). See source link for larger image.

Alcohol is widely known as a depressant drug. It is able to decrease excitatory action, and increase inhibitory action. Here, we can look at how alcohol affects the release of GABA. Ethanol increases the amount of GABA neurotransmitter released from pre-synaptic neuron in the brain, by increasing the likelihood that GABA containing vesicles fuse with the bi-layer membrane. To further induce an effect, ethanol encourages GABA to bind more easily to it's corresponding ligand-gated ion channels on the post-synaptic neuron. Subsequently, chloride ions flood into post-synaptic neuron cytoplasm, decreasing the chance that an action potential will fire. In parallel with this effect on GABA transmission, alcohol also affects the action of the excitatory neurotransmitter, glutamate. Ethanol decreases glutamate's excitatory activity, and this effect is quite dramatic considering that glutamate is used in 90% of synapses! (Source: Biological Sciences Review Volume 26, Number 2) The binding of glutamate to it's receptors on the post-synaptic neuron is blocked, thus an action potential cannot be triggered. Since glutamate is used in routes in the brain associated with learning and memory, it is common that people will suffer memory loss after a booze-fuelled night.

The imbalances between inhibitory and excitatory activity do explain the drowsiness, slow reactions and sometimes poor memory people have when drinking a significant amount of alcohol. However one observation we may have forgotten is that to many, drinking alcohol can make them feel good. From research, we know that the reward centre and the pathways associated with it are located in an area of the brain called the striatum. So far, there has been no clear link between alcohol and an effect on the action of the neurotransmitter dopamine. Recall that dopamine is involved in motivation and reward. Where is the link? Well, it is thought that the reward feedback system is usually 'kept in check by GABA inhibition. When this inhibition is suppressed, the reward system becomes more active'. Remember that alcohol does cause suppression of GABA inhibition as it encourages more GABA to bind to the post-synpatic neuron!

Above: Schematic of the brain showing the location of the striatum (yellow-orange region) (Source: Biological Sciences Review Volume 26, Number 2)

To conclude, we can see that in order to understand how alcohol can affect the nervous system, it is important to appreciate the biological cascade of events that occur during chemical transmission at the synapse. Although alcohol can be enjoyed in moderation, the public must be aware of the potential health complications associated, including liver disease, weight gain and sleep disruption. The incidence of liver disease particularly, is rising in the UK. Bear in mind that this disease not only affect adults, but also the young as well. Let us not forget also of the societal problems that can arise due to alcohol abuse, which include antisocial behaviour and violence in extreme cases.

Even today, alcohol still presents unsolved mysteries to researchers. However with continuous advances in technology, medicine, and neuroscience, how the brain is affected by substances is becoming clearer and clearer.


Additional credit: Oliver Freeman is a writer for the Biological Sciences Review and is also studying for a PhD in neuroscience.
 - Michelle Roberts, for her article published on the BBC website, 'Scientists breach brain barrier to treat sick patient'. Read more on the subject here.

Revolutionary Platinum-based Chemistry: A New Hopeful for Cancer Therapy

As many would agree, one of the most well-known treatments that cancer patients undergo is chemotherapy. Today, it is not unusual for platinum compounds to be used in chemotherapy - cisplatin is a notable example.

Above: False-colour electron micrograph of cancer cells (Source: Wellcome Collection)

In medicine, particularly pharmacology, the shape of molecules are extremely important. In cisplatin, the oxidation state of platinum is +2 and the molecule is said to be square planar. This means that all of the atoms lie in the same plane, forming a square if you were to join up the atoms with imaginary lines. Each of the groups, Cl^- (Chloride - with an oxidation state of -1) and NH₃ are called ligands, and because each of the different groups are on the same side of the molecule, the platinum compound is said to have a cis structure. In the body, cisplatin's basic chemistry works as follows:

Since, in the bloodstream there is a high concentration of chloride ions, none of the ligands on the molecule are substituted (NH₃ groups are more resistant to this substitution). However, once inside the cell the environment is very different. In fact, there is a much lower concentration of chloride ions, and the chloride ligands are replaced by water molecules. Now the cisplatin compound is activated. This is a perfect illustration of Le Chatelier's principle:

"If a dynamic equilibrium is disturbed by changing the conditions, the position of equilibrium moves to counteract the change"

(Source: Chemguide)

Above: Displayed formula of cisplatin

Although cisplatin  has proved effective, over the years, several similar drugs such as carboplatin have been produced to maximise efficiency and potency. The drug works by disrupting cell replication, thus leading to cell apoptosis (death). The mechanism for this relies on the substitution of those chloride ligands for water molecules once inside the (cancer) cell. From this point, nitrogen atoms from the nucleotides forming DNA substitute the water molecules. Water molecules tend to be easily replaced. In this situation, cisplatin  is effectively bound to the DNA, causing the nucleotide chain to bend due to formation of a 'kink'. In DNA replication, the shape of DNA is very important and many checks are made by feedback mechanisms to make sure the cell has proceed to divide by mitosis. Once cisplatin is bound, mitosis can no longer take place - cell death results.

However, current research into the field of photoactive compounds has proved promising - the research could be a step to producing cancer drugs that can be activated at the tumour site using lasar technology. Firstly, let us consider the properties of platinum. It has a silverly coloured surface (without tarnish) and is used in catalysis - catalytic converters in road vehicles is an example. So why does this metal prove useful in the body? Platinum is considered a relatively safe, it is said to be biologically compatible due to it's inability to react with body tissue. However, in medicine, what we are more concerned about is whether we can use platinum compounds. In fact, these compounds are used but scientists are aware of the toxicity of such substances. Platinum ions that are bonded to several ligands help to channel potential toxicity in a useful way, often to produce life-saving drugs.

The challenge now is to produce treatments that are even more localised to the cancer cells. This is inevitably the subject of research in universities and pharmaceutical corporations across the globe. Existing cancer drugs work well simply because cancer cells are subject to more damage than normal body cells - cancer cells proliferate at a faster rate. Note however that normal body cells can still become affected. As many may have experienced, the side effects of chemotherapy can be quite extensive, nausea and kidney damage to name a couple. The human body is simply trying to reject the foreign substance introduced, and this is what drives scientists to look for new solutions. 

The key fact to know is that whilst cisplatin and other similar drugs are not tumour specific, how they are activated can be controlled. Platinum, like many other transition metals, have multiple oxidation states. Platinum(IV), Pt⁴⁺ complexes 'have been proven to be inactive and non-toxic inside cells, but only in the dark' (Source; Chemistry Review Volume 24, Number 4). One reason for this is to do with the shape of these platinum(IV) complexes. With an oxidation state of +4, platinum is able to form 6 bonds to ligands in an octahedral arrangement. Remember than a platinum(II) compound can only form 4 bonds with ligands in a square planar structure. This higher oxidation state enables the molecule to be less reactive and therefore ligands tend to be become replaced. This is very relevant, recall that cisplatin has it's chloride ion ligands replaced by water molecules once inside the cell. However, it is important to remember that the reduced reactivity in the case of platinum(IV) compounds is true in the dark. These compounds can be photo-activated - light enables the configuration of the molecule to change. This process is irreversible:

Above: The photo-activation of a platinum complex - X and Y denote alternative ligands (Source: Chemistry Review Volume 24, Number 4)

This reaction is able to occur to due to the phenomenon of electron transition. An election which absorbs light energy is able to be promoted to a higher energy state, and therefore a higher energy orbital with an atom. In transition metal chemistry, it is common knowledge that when ligands bond to the central metal ion, this causes the d-orbitals of the metal ion to split. The orbitals are split into two levels, one with a higher energy level than the other. The very fact that these complexes can absorb light energy means that transition metal complexes are often colourful. During the above reaction, electrons in the central metal ion 'jump' to a higher energy level. Any remaining light that is not absorbed is reflected back. These electron transitions can cause multiple changes, such as a change in oxidation state of the central ion, or substitution of ligands. Controlling this activation could indeed be a useful tool in cancer therapy, it could potentially have wider applications in medicine. After activation, the cisplatin-like compound can then perform it's anti-cancer wonders. 

Above: Diagram showing that the energy of a particular wavelength of light is equal to the energy required to promote an election to a higher energy level (Source: Chemguide)

Using these platinum compounds does leave room for flexibility. For example, scientists would be able to change the ligands to vary the amount of light energy absorbed (to cause d-orbitals to split). However, getting this energy quota just right is a challenge, and is still the subject of research. 

So what are the applications in cancer treatment? Any treatments should be as safe as possible, so it is important what type of light should be used to activate the platinum complexes inside the body. Now, most complexes tend to be activated by blue or even UV light, however these frequencies of light do not penetrate tissue as well as red light does. Bear in mind that UV can damage tissue - red light seems a relatively safe option. A compromise must be made as red light would mean that it is less likely that a complex would be activated. Nonetheless, 'some promising Pt⁴⁺ complexes have been made, which are non-toxic in the dark but once activated have a high toxicity towards cancer cells'. After all, it is completely dark inside the body, therefore a laser would need to be used to activate the chosen drug. A laser would be a suitable choice due to it's precision - it would be much less likely that a healthy body cell would be affected (Source: Chemistry Review Volume 24, Number 4). 

As with any new treatment, this new concept would need to be subject to vigorous testing through a series of clinical trials. Safety and effectiveness are two crucial criteria that will need to be evaluated during the course of these trials in future. 

Additional credit: Louise Tear who wrote an article in the Chemistry Review, which was inspired by an undergraduate research project completed under the guidance of Professor Peter Sadler.

Further credit: Professor Sadler who wrote a short piece for theInformationDaily.com, 'Using precious metals to fight cancer', following research at The University of Warwick. 

Further reading: BBC, 'Chemists create new way to fight drug resistant cancer'.

Macmillan Cancer Support - 'Cisplatin - Cancer Information'

Has This Been Humanity's Deadliest Threat to Date?

Over the course of centuries, humans have witnessed the wrath of many deadly endemic, epidemic and pandemic diseases. Some notable examples include the uprising of small pox and the Bubonic plague. The number of deaths worldwide that have resulted are alarming. However, what is more profound is how fast the pathogens of these diseases spread in a population. In later years, the impact of these epidemics often become the subject of academic study in Medicine, in particular, epidemiology. In addition to these giants of infectious disease, there is another worth mentioning, which could be debated as 'the greatest medical holocaust in history' - the Spanish Flu of 1918.

Above: A Spanish flu ward at Fort Riley, Kansas, in 1918. (Source: The Guardian)

Caused by the H1N1 Influenza virus, the Spanish Flu was capable of rapid transmission, which resulted in it's success - 500 million people infected worldwide (one fifth of the world's population at that time (Source: Census.gov)). The fact that the infection numbers were indeed astronomically large, in the years post-pandemic, it was difficult to make an estimate of the mortality rate. Another reason is that many different countries around the world were affected by a preceding war, and different countries were affected to different extents. However, most sources indicate that the number of deaths ranged between 10-20% of those infected, i.e 50-100 million (Source: Archives.gov - The Deadly Virus). To put this into comparison, just over 17 million were killed over the duration of the Great War (Source: BBC). Despite the magnitude of destruction that the Spanish Flu inflicted, it has become a subject of lesser interest over the years. Looking back at these events, what could we learn to move ourselves forward in the medical field?


One of the great mysteries surrounding the Spanish Flu pandemic is that of the origin of the virus. Some of the latest media report that this virus is likely to have originated from the Far East, in particular, China. However, previous suggestions for the origin location range from Midwest America to France! It is generally accepted that the virus later mutated, causing the most destruction. According to the National Geographic, "new research is placing the flu's emergence in a forgotten episode of WW1: the shipment of Chinese labourers across Canada in sealed train cars." During the War, there was an increasing demand for labour, especially behind the British and French lines.

Above: Public notice for influenza in 1918 (Source: Wikipedia)

Unfortunately those that were infected often suffered unpleasant symptoms: bleeding from the nose and ears was common as well as (after autopsy) swollen hearts and lungs that had become solidified. Some figures showed that some lungs after autopsy measured up to six times their normal weight. The explanation for this is the build up of fluids (oedema) during the course of infection. This accumulation of fluid would have been a significant obstruction and gas exchange would have become increasingly difficult. It follows that as a result of this, many of those infected would die of asphyxiation. One of the physicians working at a military camp near Boston, Massachusetts in September 1918 describes the symptoms of asphyxiation one would typically have in vivid detail:

"Two hours after admission they have mahogany spots all over the cheek bones, and a few hours later you begin to see the cyanosis extending from their ears and spreading all over the face, until it is hard to distinguish the coloured men from the white. It is only a matter of a few hours then until death comes and is is a struggle for air until they suffocate. It is horrible. One can stand it to see one, two or twenty men, but to see these poor devils dropping like flies sort of gets on your nerves." 
                                                 
                                                                         - A physician stationed at Fort Devens, Boston, September 1918 (Source: Voices of the Pandemic) 

As well as these conditions that resulted from infection of the virus, often, many others would become ill from secondary infections such as pneumonia - a bacterial infection. The influenza virus is able to penetrate the respiratory system and damage the cilia and epithelial cells lining the lungs. The immunity of the infected is weakened due to the cells of the immune system losing their function. Thus, one becomes increasingly susceptible to pneumonia. 

(Above: Orginal photograph of the H1N1 virus, taken in the CDC Influenza Laboratory) 

As we know, the Spanish flu was caused by the H1N1 virus. What does this mean? Any virus that contain the letters H and N each followed by a number indicates that the virus is type A influenza. The letters H and N refer to haemagglutinin and neuraminidase respectively, the distinctive membrane proteins on the virus. Haemagglutinin binds to receptors on host cells. This causes fusion of the two membranes and deadly infiltration of the viral content. Neuraminidase acts at the end of the viral replication cycle - it 'cleaves' the new virus from the host cell. Now, the cycle is able to occur again and again, and other neighbouring cells become infected. Moreover, the proteins can actually prove very useful - they are extracted from circulating strains, purified, and use in a flu jab vaccine that is given every year.

However, what made H1N1 in 1918 such a big problem was the concept of genetic drift. This became apparent in 2005, when a group of American scientists sequenced the genome of the 1918 flu virus. The tissue sample came from a female patient who was buried in an Alaskan permafrost. The shift was gradual, initially being carried in an avian host. The H1N1 was able to mutate during the course of the pandemic, making it's infection very potent. A mutation in the genome would have caused the subsequent virus to produce subtly different variations of haemagglutinin and neuraminidase. As a consequence, antibodies produced by the host will no longer be able to bind to these proteins. The virus evades the immune response.

Above: The pathogenesis of an influenza A type virus (Source: Biological Sciences Review Volume 27, Number 4)

You might argue that perhaps only the most vulnerable would have been at risk. However the virus was evidently very potent and not discriminatory it would seem. The flu was prevalent in rural as well as urban areas - even the most remote parts of Alaska were affected! Usually, young adults tend to be the least affected when it comes these types of infectious diseases - their immune systems are generally well developed. However, for the Spanish flu, it was the exact opposite. This group tended to be severely affected, along with the vulnerable groups (elderly and young children). One astonishing statistic is that the average life expectancy of the USA dropped by twelve years during one year of the pandemic alone. (Source: Archives.gov)

Above: Age profile of deaths from Spanish flu (Source: Data from Centers for Disease Control and Prevention)

In the graph above, we can compare the deaths for each age group during the period 1911-1917 to the year 1918 - the year of the Spanish flu. What is unusual is the spike in deaths in the age group for young adults. Over the years, this has intrigued epidemiologists - however one theory that does exist to explain this oddity of flu epidemics is the 'cytokine storm'. This relates to the idea that the young and healthy have the most powerful and effective immune systems. However, during an infection with flu, the immune response can too excessive, becoming detrimental to health. Cytokines are chemical released by cells of the immune system during an infection to provide a means of cell communication. Some cytokines accelerate chemical processes, whilst others inhibit them. They also cause increased inflammation, swelling, and vasopermiability (the blood vessels become more permeable). Usually, this would help to fight the infection, however sometimes this response can come at the expense of an organ that has an oedema (and reduced blood supply). A consequence of this is tissue scarring, and then multiple organ failure. So, in the case of Spanish flu, an 'overreaction' of the immune system can indeed prove fatal (Source: Biological Sciences Review Volume 27, Number 4).

What could be done in the future? According to the World Health Organisation, the next pandemic 'will kill between 2 and 7.4 million people'. H5N1 (bird flu) is considered the most dangerous currently. In future, epidemiologists will need to keep watch for emerging epidemics that could potentially become catastrophic pandemics. In the field of infectious diseases, emphasis is being placed on prevention, more than ever before.

In addition to the reference provided above, credit should be given to Bethany Butcher who wrote an article on Spanish flu for the Biological Sciences Review April issue, 2015.

Additional credit: BBC - Viewpoint: The deadly disease that killed more people than WW1

Extra reading:

World Health Organisation - Influenza

Flu - NHS Choices

The Polio Virus - Close To Eradication?

Also known as Poliomyelitis, polio is an infectious disease, caused by the poliovirus. Infection can result in infantile paralysis and muscle spasms in its worse cases. The virus can be ingested through contaminated food or water, and be absorbed through the gut wall. From here it is able to move to the spinal cord and paralyse its nerves.

Above: Scanning Electron Micrograph of the poliovirus (Source: Polioeradication.org)

Typically, polio is relatively prominent in developing countries, Asia containing most of the transmission. Evidence suggests that the poliovirus has been around for a very long time, some sources quoting that it infected people in the prehistoric ages. However up until the 20th century, major epidemics were simply unknown. Until this time, the virus spread was known to be endemic - this means that in an area, the virus' transmission remained fairly constant, with no real surges in infection. In the 20th century however, Europe, followed by the Americas began to experience widespread epidemic of the disease. What is interesting is that the disease saw its highest incidence in the summer months of each year.

'At its peak in the 1940s and 1950s, polio would paralyse or kill over half a million people worldwide every year' (Wikipedia).  Franklin D. Roosevelt was one of the most notable people to be infected with the poliovirus, becoming permanently paralysed from the waist and down. (However this seems quite an unusual case as the poliovirus is typically known to induce infantile paralysis. Therefore, there is debate surrounding this specific case) This is a staggering number, considering that the rates of transmission were 'controlled' only couple of decades before this period. These rather catastrophic events initiated a global medical response, with research funding increasing dramatically.

Probably one of the most known national crises with polio was the Copenhagen polio epidemic in 1952. However epidemics of equal magnitude were spreading across America at the time.

"Anyone wandering in to Ward 19 of Copenhagen's Blegdas Hospital in the autumn of 1952 would have been confronted by an extraordinary sight. In each of the seventy beds arranged in two straight lines lay a child paralysed with polio with a hollow plastic tube inserted into the trachea through a cut in the neck - a tracheostomy - to which was attached another long piece of tubing, at the end of which was a rubber bag. Next to each bed sat a young medical student who, every few seconds, would squeeze the bag, blowing oxygen through the tubing into the child's lungs and then letting go, repeating this action for six hours at a stretch[...]According to Ann Isberg, one of the children, 'it was not a sad time', rather 'like [during the] war there was a spirit of resistance - everybody was doing their best'."

 - An account describing the atmosphere in a hospital ward, housing polio patients, from 'The Rise and Fall of Modern Medicine' written by James Le Fanu, M.D. 

Special respiratory centres were then established in the Blegdas Hospital, under the initial influence of anaesthetist Bjørn Ibsen, in order to help ventilate the polio patients (whose breathing was compromised by paralysis). This was essentially the birth of intensive care. Following these events, which constituted several 'summer plagues', in 1957, Jonas Salk, an American researcher helped synthesise the first successful polio vaccine. Choosing not to patent it, he allowed the vaccine to be distributed all over the world for free. This led to a vast decline in polio cases. By the late 1980s, many described the virus 'being close to eradication' in most countries.

Above: Polio ward in Hynes Memorial Hospital in Boston, 1955 (Source: Dailymail)

Above: An Iron Lung machine, used in the assistance of ventilation/breathing in polio patients (Source: Centers for Disease Control and Prevention's Public Health Image Library (PHIL) - via Wikipedia) 

Here is one staggering statistic: 'Polio cases have decreased by over 99% since 1988, from an 
estimated 350 000 cases then, to 416 reported cases in 2013' (The World Health Organisation Polio Fact Sheet)

Despite this, new cases of polio have been emerging in Afghanistan, Pakistan and Nigeria. In 2014, the World Health Organisation saw that this surge in cases meant the declaration of a public health emergency of international concern (PHEIC). The vital key to eradicating polio completely is nationwide herd vaccinations, as the virus cannot survive for long outside a host.

The Final Stages in Eradicating Polio

As of early 2015, scientists have been collaborating internationally in order to develop a synthetic vaccine in the hope of eradicating the last remaining strain of the poliovirus. Together, the World Health Organisation and the Bill & Melinda Gates Foundation have provided a $674,000 (£438,000) grant to fund the research. The main problem with current vaccines is that because they utilise the weakened (attenuated) form of the virus, in some patients, this may initiate an immune response. This would mean that the virus can be 'reactivated' and passed on to those that have not been vaccinated. However a synthetic vaccine means no genetic material which essentially indicates that the vaccine contains no virus.


We are extremely close to eradicating the poliovirus off the face of the Earth. What a human feat that would be.


References

In addition to sources given above:
- Credit to the World Health Organisation for their information and data on the poliovirus and the polio vaccinations
- Additional Credit to BBC Science Correspondent, Jonathan Amos for his article on the new synthetic vaccine for polio, 'Synthetic vaccine sought to finally eradicate polio' (14th February 2015) Read more.
- Additional Credit to James Le Fanu's 'The Rise and Fall of Modern Medicine' which features the events surrounding the Copenhagen polio epidemic and the birth of intensive care.

Hepatitis C - Can We Use Genetics To Find Effective Treatments?

As devastating as viral infections go, Hepatitis C is one of the most severe, in worst cases leading to cirrhosis - liver tissue scarring. There have been cases where individuals have developed cancer as a result of the destruction due to the Hepatitis C virus. The success of the Hepatitis C virus is largely due to the survival of its most deadliest strains. The fact that humans are the only species as far as we know that can be infected with HCV makes us somewhat more vulnerable. What is more interesting is that despite all our current knowledge on viral replication and adaptation, the mechanism of this virus infiltrating cells and causing damage is not fully understood. You could argue this 'void' in our scientific knowledge is preventing us from devising effective treatments, not only to this particular type of infection, but others too. However just like any other virus strain, the Hepatitis C strain which causes disease does utilise the host cells 'machinery' in order to replicate itself multiple times. It follows that whole new virions are produced from the newly synthesised viral protein. Despite there being some individuals who are able to fight off the virus, most people develop a chronic infection which can last as long as a lifetime. Continued degrading of the liver over a prolonged period means that eventually the liver cells lose function -  only a liver transplant can save the life of the patient.

What seems reassuring statistically, is that according to the World Health Organisation, around 3% of people worldwide are affected severely by the Hepatitis C virus (HCV). A small percentage one may consider, however it equates to a very large quantity. Additionally, a large number of people may have not been diagnosed with the infection as the infection takes time to develop. This can only mean that the actual number of people affected chronically with HCV is much higher.

A Summary of HCV Transmission:

A blood-bourne infection, HCV is commonly transmitted through (vascular) medical operations, or through intravenous drug usage. There have been nationwide catastrophes in some countries where blood, contaminated by HCV, has been used for transfusions. The identification of the virus was too late, and many people were medically affected.

The origin of the spread of HCV is largely unknown, although many agree that it could have been initially spread by some kind of vector, a mosquito being a predictable example. It has been discovered that the virus can spread through sexual transmission, however blood-to-blood contact is seen as the most efficient method of the virus' transmission.

Above: Electron Micrograph of the Hepatits C Virus (HCV) isolated from cell culture (Wikipedia)

The Significance of the Viral Genome:

The HCV, as characteristic of many viruses, is able to mutate at a frequent rate, making it very difficult to develop a long-lasting vaccine. The length of its genome is relatively short at around 10000 nucleotides long. The primary reason for the rapid mutating of the HCV genome, is that unlike in humans, the HCV virus has no mechanisms in place to proof-read its own DNA. This frequency results in copying errors during the process of DNA replication. Combining this feature (or rather a lack of it), with HCV's ability to replicate at an extraordinary rate, results in many mutations in the viral DNA sequence.

To most people, a mutation is seen an event detrimental to the host organisms, however this isn't always the case. In viruses, due to the large number of mutations that occur, mutations can sometimes be advantageous. Therefore the virus is able to acquire a protein that serves valuable to virus, allowing it to survive in more extreme conditions. One application of this is that an advantageous mutation can cause a virus to the evade the host organism's immune response. The host's own cells may recognise the new viral proteins as 'self' and thus fail to identify the intruder.

As mentioned, the HCV constitutes many different strains, and there is scientific evidence of this. Comparing HCV genomes from around the world, where it has caused infection in the local population, has given scientists insight into the impressive genetic diversity of this virus. Such diversity is simply uncharacteristic of most organisms, take humans as an example: 'the difference between the DNA sequences of individual humans is less than 1%'. However no matter how genetically diverse the HCV is, liver disease still developed upon infection.

Scientists have managed to categorise the differences between HCV strains, and classify the different HCV genotypes. The seven major genotypes of HCV range from G1 to G7. Each strain is prominent in different areas of the globe:

• G1 - found in Africa (endemic - constant transmission rates) as well as parts of Europe, the USA and Japan (causes epidemics - greatly fluctuating transmission rates).
• G2 - found in  Western Africa (endemic) and near Mexico
• G3 - found in Asia (endemic) - in and around Northern India
• G4 - found in (Central) Africa (endemic) 
• G5 - found in (southern) Africa (endemic)
• G6 - found in (Eastern) Asia (endemic)
• G7 - found in (Central) Africa

Above: World map showing the distribution of various strains of HCV and relative proportions of different genome types in each area (Hepatitis C Education & Prevention Society)

What is intriguing is that worldwide medical data suggests that some strains of HCV are statistically easier to treat than others. Take G1 and G2 as examples. G1 is in fact the most common type of HCV in the UK and is notoriously difficult to eradicate, 'only 50% of G1-infected people are treated successfully'. However G2 induced Hepatitis seems easier to treat, with success rates as high as 80%.

Looking to the Future:

Recent developments in genome sequencing, drug synthesis and virology has enabled scientists to develop potential drugs to combat this deadly virus. In today's world however the HCV isn't the only significant threat to global health, with HIV/AIDS being a notable contender. The primary function of these new drugs is to inhibit particular stages of the viral life cycle, by targeting viral enzymes. This is a more virus-directed approach which contrasts greatly to old drugs, which only focused on increasing the strength and effectiveness of the host's immune system. Additionally, knowing the differences in the genotype between strains of HCV will enable scientists to develop drugs capable of destroying all strains in equal effectiveness.

So who will win this 'evolutionary arms race'?

References:

Credit to Dr Rebecca Gray PhD, who is studying the evolution of HCV and is now a research fellow at the University of Oxford for her original article on Hepatitis C published in the Biological Sciences Review (Volume 26, Number 1).

Additional credit - 'Hepatitis C - NHS Choices'. Read more.
(Image references are given in captions)

Further reading:
 - The World Health Organisation provides more information on the Hepatitis C Virus. Read more

New Blood Test For The Detection of Alzheimer's

One of the big health stories that have emerged this week is the formulation of a new blood test which will have the potential 'to detect which people with failing memories will go on to develop Alzheimer's disease'. When I quote 'failing memories', what I am referring to is mild cognitive impairment. Statistically, 60% of those who have this form of memory loss go on to develop Alzheimer's. For the general public, it is imperative to note that this a diagnostic solution, not a cure. Nevertheless, getting a correct diagnosis with vast amounts of research can lead on to the synthesis of new drugs which can be used to treat the disease. Increases in research funding would allow scientists to draw closer to a solution - but this is difficult as scientific research isn't advancing at a rate we might think. There are inevitably restrictions due to funding and legal issues.

Only 'after a decades work', has this new blood test been derived which shows the unbelievable timescale of innovation. The test involves looking at 10 sets of proteins that are suspended in the blood. Kings College London in conjunction with Proteome Sciences have published the study. The claim is that this test 'can predict the onset of Alzheimer's in the next 12 months in people with memory problems with an accuracy of 87%'. The cost of such a test can be estimated at around £100 to £300.

Instantly in my brain I question the "87%" accuracy as I'm concerned that for a test as significant as this, a very high high accuracy is desired in order to diagnose the right people. Alzhiemer's and other forms of dementia are one of the most common diseases in our society - according to David Cameron, it "stands alongside cancer as one of the greatest enemies of humanity". I fear he is right. With an ageing population and with the development of the latest treatments to prolong life expectancy, epidemiological evidence says the incidence of these diseases are rising.

With this new test, the key turning point is that people will be identified as having the potential to go on to develop Alzheimer's. Not simply diagnosing those who have Alzheimer's. This is crucial. Read enough into the disease and you'll probably realise that Alzheimer's is very complex. This is why we need to diagnose people at the earliest opportunity. Professor Simon Lovestone from Kings College London puts it perfectly: "Alzheimer's begins to affect the brain many years before patients are diagnosed with the disease. Many of our drug trials fail because by the time patients are given the drugs, the brain has already been too severely affected".


The scientists in the investigation wrote for the journal Alzheimer's and Dementia, and investigated in a variety of proteins that have been linked to Alzheimer's before. Blood samples were taken from 1148 individuals. A large sample some may think, but the size of the problem we are confronting means the next stage for this test is for it to be trialled on around 5000-10000 people. 


A larger sample size means more reliability which will make this study more valid and thus promising. Also getting more accurate results with the test will reduce the risk of misdiagnosis which is outstandingly important. 

Personally I believe this to be positive and promising news, but we need to be sure that this will work. I hope that in the end this could develop into effective treatment for one of the most devastating diseases that exist in our society today. 

Credit to Sarah Boseley, health editor for The Guardian on the original article. More on the story can be followed here.

Should NHS End-of-life Social Care be Free?

With an increasingly ageing population, there is more need than ever for social care in communities to support older patients. Currently the NHS is spending around £69 million on this social care for cancer patents alone.

Personally I think it would be very appropriate to provide free care to those nearing the end of their lives. The trouble is at the moment is that around half of these patients die in hospital - the costs of maintenance to the NHS total to large sums.

In a MacMillan Cancer Support survey, 8 out of 10 people would prefer to die in their own home. However from statistical data we can see that many people have it "against their wishes".

Caring for these patients in their community would substantially reduce costs to the NHS from around £685 million to around £340 million a year. In my view it would be morally wrong to have a patients will not fulfilled, however it is disheartening to see that not everyone can be accommodated.

A Department of Health representative has said that "We want to make sure that people nearing the end of their lives can choose where to spend their last days and have more of a say on how they are cared for". 


Credit to Nick Triggle (BBC News Health Correspondent) for the original article which can be found here. 

The Incredible Human Hand!

I remember watching a couple of months ago, a documentary about the anatomy of the human hand. However I revisited the documentary not too long ago and I thought it would be great to post on here how extraordinary it was.

I must put it simply… it was truly fascinating! Never before on a television broadcast had a dissection been shown to the general public audience. It amazes me how the producers managed to obtain permission to do so. It just shows their passion for showing the world how remarkable the human body really is.

The programme was broadcasted by the BBC, this episode called Dissected: The Incredible Human Hand, presented by George McGavin.

The documentary can be seen here:



At the start of the programme, it was definitely a new experience for me when an arm was brought onto the dissection table. An unnamed person has donated this part of their body to medical science, and I appreciate that enormously as this programme did open my eyes a little more and enrich my learning experience.

Mr Donald Sammut, one of the worlds leading hand surgeons performed this dissection.



An incision was first made at the top of the forearm, and a skin "flap" was created in order to remove the integumentary layer and adipose (fat) tissue. Once this was done, the main muscles of the forearm could be seen. In association with these muscles, tendons are seen to be attached to each end of the muscle - and as I know from my biology classes, tendons transmit the forces of muscles onto bones.

At one point, Mr Sammut used his surgical instrument to tug on the tendon, which in turn caused the 5th digit (little finger) to be pulled upwards - almost if it were about to grip onto an object. I found this absolutely fascinating; a dead, motionless hand becoming animated once more.

How complex and intricate the very details of the internal structure are made me appreciate how we are able to carry out an infinitely diverse array of tasks with our hands.

Obviously you could see each tendon for each digit which also shows the very mechanical nature of our hands.

A tough protective layer was then removed which is located directly below the skin. This allows us to see the vital major structures and fine details such as the major artery and the major nerves.

The many muscles around our thumbs is quite extraordinary as it allows us to carry out a great multitude of tasks using various grips. Many ligaments hold in place a saddle joint made up of the thumb meta-carpel and the trapezium to minimise injury. This joint is in fact according to Mr Sammut one of the most likely to wear over time. What was most impressive to me in this section of the documentary was how the tendons are arranged in the hand. Moving towards the distal part of the hand from the wrist, the tendons are each encased in a sheath which offers protection. Quentin, the dissection assistant notes that this sheath, when removed allows the tendons to be seen in their 'pristine' condition. The deep tendon runs all the way to the most distal joint, and the superficial one splits part-way to attach to the one-but-most-distal joint. This to me is a marvel of biomechanics.

According to Quentin, the nerves are "probably the most difficult part in the hand to dissect, but it also makes them the most exciting". It's truly amazing how every part of the hand, every tissue in fact is supplied with a nervous network. At the fingertips alone, 20,000 nerves terminate at each finger to allow for as much sensory information to be obtained from the environment.

Overall, what was most surprising is that if we were to lose one finger by choice, the index finger would be the one we could 'most do without'. In the words of Mr Donald Sammut:

"Although it is included in everything [you] do, you can exclude it from everything you do."

I highly recommend anyone to watch this documentary, even if it is just for appreciation!

Feel free to leave a comment below, I'd be interested to hear what you thought about that dissection!

The Potential of Recombinant Proteins to Treat Disease

An article in the Biological Sciences Review (Volume 23, Number 4) grabbed my attention today, although it was published in April 2014. Nonetheless I feel it is very relevant. It was about how recombinant proteins can be used to treat certain chronic diseases, rheumatoid arthritis and multiple sclerosis are just a named couple.

I don't feel I should need to go into all the theory about protein synthesis, but in case you weren't sure, below is a very useful visual intuition:



Recombinant proteins are synthesised by manipulating the cell and almost 'tricking' the cell to making the desired proteins we require. Usually this is achieved by introducing some (foreign) DNA into the cell which codes for the functional protein, then the normal 'protein expression' is able to follow using ribosomes. One example of this would be insulin protein being synthesised by bacteria by using it's plasmid as a vector. One thing to note is that if mammalian cells and bacterial cells were to be used, the protein product many not necessarily be identical as the protein folding procedure may slightly differ for eukaryotic and prokaryotic cells.

Examples of recombinant proteins include insulin as mentioned and therapeutic antibodies.

What I find very exciting is that these antibodies are able to target specific cells - you may have heard of monoclonal antibodies under the same context. This could mean the targeting of cancer cells, as cancer cells have a unique antigen on their plasmalemma. Therefore therapeutic antibodies can be engineered to target these cells. The formation of an antigen-antibody complex can result in a number of consequences: inhibition of growth, immobilisation (pathogenic cells) and detoxification.


One interesting idea from the article explains how using therapeutic antibodies may help to lessen the pain for individuals with chronic diseases such as arthritis, by inhibiting the activity of certain ion channels in nerve cells.

Ion channels are transmembrane (intergal) proteins that allow passage of ions from one cell to another - pain signals are achieved in this way. Some rare individuals have equally the rare inability to feel pain. This condition was explained by scientists who saw that there was a rare mutation in the gene SCN9A (this gene codes for the synthesis of these ion channels). Therefore using this fascinating occurrence there is the potential of using specific therapeutic antibodies to target these particular ion channels. The result of this will inevitably be a reduction in the number of functioning ion channels.

I appreciate that this technique may not cure the disease for good, but this would be a major breakthrough in pain management for chronic diseases. These conditions have dramatic effects on an individuals quality of life, so lessening the pain can improve their mental health.


It would be a major achievement to get this treatment underway. However like with any drug rigorous testing over many stages must be carried out first.

I look forward to seeing the progress of this idea in the future…

Credit to Katharine Cain, postdoctoral scientist at UCB pharmaceutical company, for the original article.

New 'Non-invasive' Technique for Identifying Oesophageal Cancer

Scientists from the University of Southampton being part of a larger international effort, have recently trialed a new technique which would allow oesophageal cancer to be diagnosed sooner for those who are likely to develop it.

A condition known as Barrett's oesophagus (or complications with 'heartburn') is a problem where people have frequent acid reflux. This is where stomach acid enters the oesophageal tube via the cardiac sphincter when lumen is not closed sufficiently. This condition if serious can ultimately be the cause of subsequent oesophageal cancer.

The main discovery was the identification of two genes that can mutate which could lead onto oesophageal cancer.

However to identify these genes in the first place, DNA inevitably needed to be sequenced. Scientists used modern techniques to sequence the DNA of patients with Barrett's oesophagus and of those with oesophagul cancer. The findings were published in the journal Nature Genetics. This way of identification is coupled with a relatively new method of obtaining the mutated cells from the oesophageal lining. A "sponge-on-a-string" test is used to obtain the cell samples says Rebecca Fitzgerald, professor at the University of Cambridge (MRC Cancer Unit).

A non-invasive technique such as this is a major advantage in my view. It could mean a lower probability of the potential subsequent complications of surgery for example. I am sure for many patients, a non-invasive technique is very desirable.

Oesophageal cancer is one of the hardest cancers to diagnose early and has a low survival rate according to the American Cancer Society. If this technique is widely successful then this will ultimately lead to treatment being available to those who are enduring the early stages of this cancer.

I encourage further reading on the article which can be found here. (Credit to Catharine Paddock PhD for original article)

A New Method of Organ Preservation

Recently I came across an article on the BBC explaining a new technique on preserving organs shortly before transplantation. To keep the organs 'fresh', they will need to be 'supercooled' according to United States researchers. As with most scientific trials, this technique was first experimented on the organs of animals (specifically rat livers) and the results published in Nature Medicine. According to this the organs can be preserved for up to 3 days using this technique! Using current methods organs can only  remain viable for around 24 hours.

I think that in the long-term this technique can be cost effective for the NHS and seems like a very efficient method of preserving organs despite the initial start-up costs of implementing this resource into hospitals.

However we haven't yet tested this technique on human organs which is an important factor to consider. It's also interesting to know how this process works:

The main principle to note is that as soon as an organ is removed from the body, individual cells begin to die as they are stripped of their normal environment. However cooling aims to slow this process as the metabolic rate of the cells themselves is slowed.

But the main advantage here is that ultimately if this process works on human organs, donor matching will result more successfully. Especially as in current times the demand for organs without rejection is very high, this technique could be a major step in my opinion.

The important question now is can this technique be used on a 1.5kg human liver compared to a 10g rat liver? With more cells and a larger mass, I imagine preserving a larger organ will provide more difficulty.

Credit to Dr Korkut Uygun and his team of researchers at Harvard Medical School.

Click here to read more on the subject.

Beginnings...

With my growing interest for medicine over the last few years, I have arrived at a point where I think it may be appropriate to express some of my views on today's changing events in the medical field. The field of medicine is one of profound innovation yet very personal to many. It is greatly affected by economics and politics - our NHS system has had significant reforms in recent times. Changes in the structure of the NHS have had a knock-on effect even right down to the patient level, whether it is receiving the right treatment or whether one can afford the treatment at all.

In fact one of the most controversial issues surrounding the NHS and the government is whether the NHS as an organisation will enter privatisation. When most people think of privatisation, they are reminded of the US-style health insurance 'fee for service' plans. For many this may mean no easy access to essential healthcare anymore, but could indicate 'big bucks' for emerging private health companies such as Virgin Care, a sub-category of Richard Branson's Virgin empire. An essay I have written on whether the NHS should be privatised can be seen here. I encourage a read to anyone who isn't particularly sure of what privatisation is and it's implications.

Also I will look forward to commenting on any medically related books I read that spark an interest in me.